Center-Authored Papers

Filters: Author is Horowitz, Mary M  [Clear All Filters]
Journal Article
Pagel JM, Appelbaum FR, Eary JF, Rajendran J, Fisher DR, Gooley T, Ruffner K, Nemecek E, Sickle E, Durack L et al..  2006.  131I-anti-CD45 antibody plus busulfan and cyclophosphamide before allogeneic hematopoietic cell transplantation for treatment of acute myeloid leukemia in first remission.. Blood. 107(5):2184-91. Abstract
Joshua TV, Rizzo DJ, Zhang M-J, Hari PN, Kurian S, Pasquini M, Majhail NS, Lee SJ, Horowitz MM.  2010.  Access to hematopoietic stem cell transplantation: effect of race and sex.. Cancer. 116(14):3469-76. Abstract
Eapen M, Wang T, Veys PA, Boelens JJ, St Martin A, Spellman S, Bonfim CS, Brady C, Cant AJ, Dalle J-H et al..  2017.  Allele-level HLA matching for umbilical cord blood transplantation for non-malignant diseases in children: a retrospective analysis.. The Lancet. Haematology. Abstract
Kalaycio ME, Kukreja M, Woolfrey AE, Szer J, Cortes J, Maziarz RT, Bolwell BJ, Buser A, Copelan E, Gale RP et al..  2010.  Allogeneic hematopoietic cell transplant for prolymphocytic leukemia.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 16(4):543-7. Abstract
Ballen KK, Woolfrey AE, Zhu X, Woo Ahn K, Wirk B, Arora M, George B, Savani BN, Bolwell B, Porter DL et al..  2012.  Allogeneic Hematopoietic Cell Transplantation for Advanced Polycythemia Vera and Essential Thrombocythemia.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. Abstract
Weisdorf DJ, Millard HR, Horowitz MM, Hyare PS, Champlin R, Ho V, Mielcarek M, Rezvani A, Stockerl-Goldstein K, Khoury HJ et al..  2017.  Allogeneic transplantation for advanced acute myeloid leukemia: The value of complete remission.. Cancer. Abstract
Krishnan A, Pasquini MC, Logan B, Stadtmauer EA, Vesole DH, Alyea E, Antin JH, Comenzo R, Goodman S, Hari P et al..  2011.  Autologous haemopoietic stem-cell transplantation followed by allogeneic or autologous haemopoietic stem-cell transplantation in patients with multiple myeloma (BMT CTN 0102): a phase 3 biological assignment trial.. The lancet oncology. Abstract
Copelan EA, Hamilton BK, Avalos B, Woo Ahn K, Bolwell BJ, Zhu X, Aljurf M, van Besien K, Bredeson C, Cahn J-Y et al..  2013.  Better leukemia-free and overall survival in AML in first remission following cyclophosphamide in combination with busulfan compared with TBI.. Blood. 122(24):3863-70. Abstract
Appelbaum FR, Anasetti C, Antin JH, Atkins H, Davies S, Devine S, Giralt S, Heslop H, Laport G, Lee SJ et al..  2015.  Blood and marrow transplant clinical trials network state of the Science Symposium 2014.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 21(2):202-24.
Eapen M, Logan BR, Horowitz MM, Zhong X, Perales M-A, Lee SJ, Rocha V, Soiffer RJ, Champlin RE.  2015.  Bone marrow or peripheral blood for reduced-intensity conditioning unrelated donor transplantation.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 33(4):364-9. Abstract
Arora M, Hemmer MT, Woo Ahn K, Klein JP, Cutler CS, Urbano-Ispizua A, Couriel DR, Alousi AM, Gale RP, Inamoto Y et al..  2015.  Center for International Blood and Marrow Transplant Research chronic graft-versus-host disease risk score predicts mortality in an independent validation cohort.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 21(4):640-5. Abstract
Shaw BE, Brazauskas R, Millard HR, Fonstad R, Flynn KE, Abernethy A, Vogel J, Petroske C, Mattila D, Drexler R et al..  2017.  Centralized patient-reported outcome data collection in transplantation is feasible and clinically meaningful.. Cancer. Abstract
Arora M, Klein JP, Weisdorf DJ, Hassebroek A, Flowers MED, Cutler CS, Urbano-Ispizua A, Antin JH, Bolwell BJ, Boyiadzis M et al..  2011.  Chronic GVHD risk score: a Center for International Blood and Marrow Transplant Research analysis.. Blood. 117(24):6714-20. Abstract
Pasquini MC, Devine S, Mendizabal A, Baden LR, Wingard JR, Lazarus HM, Appelbaum FR, Keever-Taylor CA, Horowitz MM, Carter S et al..  2012.  Comparative Outcomes of Donor Graft CD34+ Selection and Immune Suppressive Therapy As Graft-Versus-Host Disease Prophylaxis for Patients With Acute Myeloid Leukemia in Complete Remission Undergoing HLA-Matched Sibling Allogeneic Hematopoietic Cell Transpl. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 30(26):3194-201. Abstract
Khera N, Majhail NS, Brazauskas R, Wang Z, He N, Aljurf MD, Akpek G, Atsuta Y, Beattie S, Bredeson CN et al..  2015.  Comparison of Characteristics and Outcomes of Trial Participants and Non-participants: Example of Blood and Marrow Transplant Clinical Trials Network (BMT-CTN) 0201 Trial.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. Abstract
Copelan EA, Avalos BR, Woo Ahn K, Zhu X, Gale RP, Grunwald MR, Hamadani M, Hamilton BK, Hale GA, Marks DI et al..  2015.  Comparison of outcomes of allogeneic transplantation for chronic myeloid leukemia with cyclophosphamide in combination with intravenous busulfan, oral busulfan, or total body irradiation.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 21(3):552-8. Abstract
Lee SJ, Logan B, Westervelt P, Cutler C, Woolfrey A, Khan SP, Waller EK, Maziarz RT, Wu J, Shaw BE et al..  2016.  Comparison of Patient-Reported Outcomes in 5-Year Survivors Who Received Bone Marrow vs Peripheral Blood Unrelated Donor Transplantation: Long-term Follow-up of a Randomized Clinical Trial.. JAMA oncology. Abstract
Anderlini P, Wu J, Gersten I, Ewell M, Tolar J, Antin JH, Adams R, Arai S, Eames G, Horwitz ME et al..  2015.  Cyclophosphamide conditioning in patients with severe aplastic anaemia given unrelated marrow transplantation: a phase 1–2 dose de-escalation study. The Lancet Haematology. 2(9):e367-e375. Abstract
Kollman C, Spellman SR, Zhang M-J, Hassebroek A, Anasetti C, Antin JH, Champlin RE, Confer DL, Dipersio JF, Fernandez-Viña M et al..  2015.  The effect of donor characteristics on survival after unrelated donor transplantation for hematologic malignancy.. Blood. Abstract
Eapen M, Le Rademacher J, Antin JH, Champlin RE, Carreras J, Fay J, Passweg JR, Tolar J, Horowitz MM, Marsh JCW et al..  2011.  Effect of stem cell source on outcomes after unrelated donor transplantation in severe aplastic anemia.. Blood. 118(9):2618-21. Abstract
Fleischhauer K, Shaw BE, Gooley T, Malkki M, Bardy P, Bignon J-D, Dubois V, Horowitz MM, Madrigal AJ, Morishima Y et al..  2012.  Effect of T-cell-epitope matching at HLA-DPB1 in recipients of unrelated-donor haemopoietic-cell transplantation: a retrospective study.. The lancet oncology. 13(4):366-374. Abstract
Jacobsen PB, Le-Rademacher J, Jim H, Syrjala K, Wingard JR, Logan B, Wu J, Majhail NS, Wood W, Rizzo DJ et al..  2014.  Exercise and stress management training prior to hematopoietic cell transplantation: blood and marrow transplant clinical trials network (bmt ctn) 0902.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. Abstract
Tolar J, Deeg HJ, Arai S, Horwitz M, Antin JH, McCarty JM, Adams RH, Ewell M, Leifer ES, Gersten ID et al..  2012.  Fludarabine-based conditioning for marrow transplantation from unrelated donors in severe aplastic anemia: early results of a cyclophosphamide dose deescalation study show life-threatening adverse events at predefined cyclophosphamide dose levels.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 18(7):1007-11. Abstract
Ringdén O, Pavletic SZ, Anasetti C, Barrett JA, Wang T, Wang D, Antin JH, Di Bartolomeo P, Bolwell BJ, Bredeson C et al..  2009.  The graft-versus-leukemia effect using matched unrelated donors is not superior to HLA-identical siblings for hematopoietic stem cell transplantation.. Blood. 113(13):3110-8. Abstract
Ciurea SO, Zhang M-J, Bacigalupo AA, Bashey A, Appelbaum FR, Aljitawi OS, Armand P, Antin JH, Chen J, Devine SM et al..  2015.  Haploidentical transplant with post-transplant cyclophosphamide versus matched unrelated donor transplant for acute myeloid leukemia.. Blood. Abstract